Greylin Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.76M | Sell |
|
|||||
|
2018
Q4 | $3.28M | Sell |
|
|||||
|
2018
Q3 | $5.1M | Sell |
|
|||||
|
2018
Q2 | $5.89M | Sell |
|
|||||
|
2018
Q1 | $4.22M | Sell |
|
|||||
|
2017
Q4 | $4.75M | Buy |
|
|||||
|
2017
Q3 | $4.05M | Sell |
|
|||||
|
2017
Q2 | $9.78M | Buy |
|
|||||
|
2017
Q1 | $6.91M | Buy |
|
|||||
|
2016
Q4 | $3.37M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $287K | Sell |
|
|||||
|
2015
Q3 | $275K | Sell |
|
|||||
|
2015
Q2 | $406K | Sell |
|
|||||
|
2015
Q1 | $464K | Sell |
|
|||||
|
2014
Q4 | $590K | Sell |
|
|||||
|
2014
Q3 | $576K | Sell |
|
|||||
|
2014
Q2 | $635K | Sell |
|
|||||
|
2014
Q1 | $714K | Buy |
|
|||||
|
2013
Q4 | $453K | Buy |
|